← Back to BIO-B

Bio-Rad Laboratories, Inc. Class B Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 04/08/2026Sep 2025Filed 29/10/2025Jun 2025Filed 04/08/2026Mar 2025Filed 04/08/2026Dec 2024Filed 14/02/2025Sep 2024Filed 29/10/2025Jun 2024Filed 29/10/2025
$651$592$653$652$585$668$650$639
$371−$527−$342$318$64−$716$653−$2,166
$13.85−$19.55−$12.70$11.67$2.29−$25.57$23.34−$76.26
27272727282828

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.